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and HBV.Hepatitis B viral (HBV) infection is a major health problem globally and more prevalent in Pakistan, 
which is the main etiological agent of chronic hepatitis B, hepatocellular carcinoma and liver cirrhosis. 
A total of 659 HBsAg ELISA positive patients out of 16825 patients during July to October, 2013 were 
screened for HBV by real-time polymerase chain reaction. Out of 659, 522 (79.21%) were found positive 
for HBV, of which 318 (over all 4.4%) were male, while 341 (over all 3.55%) were female. The HBV PCR 
positivity rate was 80.18% (n=255) in males and 78.30% (n=267) in females patients. Among different 
age groups HBV PCR positivity was highest (n=181, 83.41%) in the age group of 31 to 40 years. HBV 
genome was detected in 79.21% of HBsAg positive samples, showing that HBsAg on ELISA is much 
more sensitive than PCR as HBV shows chronic conditions and both of the tests are needed against HBV.
According to World Health Organization (WHO) approximately more than 2 billion people are 
infected with HBV globally, including about 400 million 
people with chronic stage of infection while every year, 
approximately 0.6 million die due to HBV associated 
diseases all over the world (Goldstein et al., 2005; Alam 
et al., 2007). Pakistan is an extremely endemic area for 
HBV with an estimated 9 million people infected with 
HBV (Noorali et al., 2008; Hakim et al., 2008). The 
Intraprovince prevalence of the hepatitis B was very high 
in Balochistan (i.e. 4.3%) while it was 2.5% in Sindh, 2.4% 
in Punjab and 1.3% in Khyber Pakhtunkhwa (Choudhary 
et al., 2005). Early diagnosis of HBV infection is very 
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important for the prevention of its further transmission. 
Various serological and molecular based diagnostic 
techniques are used (Wolters et al., 1985), of which ELISA 
is very common. This technique suffers from an abundance 
of false positive result due to suboptimal sensitivity and 
specificity (Mahoney, 1999). Lately, real time PCR (RT-
PCR) has been widely used for HBV DNA detection and 
quantification. The current study was therefore designed 
to reassess ELISA positive cases by using reverse 
transcriptase real time PCR (RT RT-PCR) to confirm the 
specificity and sensitivity of RT-PCR for HBV diagnosis.
Materials and methods
All the HBsAg ELISA positive serum samples were 
received along with specifically designed data sheets at 
Chiragh Diagnostic Complex, Lahore, Pakistan during 
July to October, 2013 from seven collection centers located 
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in different districts i.e. Lahore, Dipal Pur, Rahim Yar 
Khan, Liaqat Pur, Pak Pattan, Gujranwala, and Khanpur 
at Punjab Province Pakistan. The study was approved by 
the ethical committee of Microbiology department, Kohat 
University of Sciences and Technology, Kohat.
Quantification of HBV DNA in all HBsAg positive 
samples were performed by PikoReal 24 Real time PCR 
system (Thermo Fisher Scientific, Lenixa, KS 66285, 
USA) using HBV DNA quantification kit AmpliSens, 
HBV-FRT (Federal Budget Institute of Science, Moscow 
111123, Russia) by using the prescribed protocol given in 
the kit with some modifications. The amplified product was 
detected by using fluorescent dyes in RT-PCR, which were 
linked to the oligonucleotide probes to bind specifically 
with the amplified product and then the fluorescent probes 
were detected after each replication cycle. The lower 
detection limit of the assay used was 5.0 ×102 IU/ml while 
its higher detection limit was 5.0 × 108 IU/ml.
Statistical analysis of the available data was 
performed by Chi-square test and one way ANOVA test 
“STATISTIX”, version 9.0, Korean made software. The P 
value less than 0.05 were considered significant. 
Results and discussion
The current study was conducted for the prevalence 
rate of HBsAg in different districts of Punjab Province. 
Out of a total of 16825 samples, 659 (3.92%) samples 
were positive for HBsAg. Table I shows 4.4% prevalence 
rate of HBV in male and 3.55% in the female patients. 
Likewise patients between 31-40 years of age showed 
5.11% prevalence followed by 4.07% in 41-50 years old 
age group.
Among different regions of Punjab, highest prevalence 
was detected in Rahim Yar Khan (8%), followed by 6.99%, 
5.32% and 5% in Liaqatpur, Pak Pattan and Gujranwala, 
respectively. The lowest prevalence rate was 2.3% in 
Lahore and 3% in Dipalpur.
Real time PCR detected HBV DNA in 79.21% (522) 
of the HBsAg positive (659) samples. The current study 
showed that Lahore had the highest number of true HBV 
positive cases (n=115, 84.55%), followed by Rahim Yar 
Khan (80.5%) Liaqatpur (80%) and Khanpur (n=54, 
73.79%) (Table I).
The HBV positivity was 80.18% (n=255) in male, 
and 78.30% (n=267) in the female subjects (Table II).
Moreover, the incidence of PCR HBV positivity was 
low (n=40, 72.72%) in the age group above 50 years while 
the highest prevalence (n=181, 83.41%) was reported in 
the age group of 31 to 40 years (Table I).
In Pakistan, one of the major public health problems 
is chronic viral hepatitis. HBV prevalence rates have been 
reported as high as 10% for Pakistan (Malik and Tariq, 
1993).
In the past several years, the role of quantified 
serum HBsAg in the surveillance of treatment efficacy 
has evinced lot of interest. HBsAg seroclearance confers 
a favorable prognosis in cirrhosis and HCC (Yuen et al., 
2008). The risk of hepatocellular tumorigenesis is lower 
in the patients with a clearance of serum HBsAg after 
interferon α-based antiviral therapy (Fattovich et al., 
1998). High levels of HBsAg increase the risk of HCC and 
vice versa (Tseng et al., 2012).
Table I.- Prevalence of HBsAg and PCR detection of 
HBV (%) in both male and female subjects of different 
age groups from different geographical areas of Punjab 
Province.
Characte- 
ristics
Total 
subject
Positive 
HbsAg
Prevalence 
(%)
HBV 
detected (%)
Sex
Male 7230 318 4.4 -
Female 9595 341 3.55 -
Age group
10-20 625 19 3.04 15 (78.94)
21-30 4500 170 3.78 141 (82.94
31-40 4250 217 2.11 181 (83.41)
41-50 4860 198 4.07 145 (73.23)
> 50 2590 55 2.12 40 (72.72)
Total 522 (79.21)
Area
Lahore 5915 136 2.3 115(84.55)
Dipalpur 2930 88 3 67(76.13)
RY Khan 1287 103 8 83(80.58)
Liaqatpur 1145 80 6.99 64 (80)
Pak Pattan 1823 97 5.32 76 (78.35)
Gujranwala 1640 82 5 63 (76.82)
Khanpur 2085 73 3.5 54 (73.79)
Total 16825 659 3.92 522 (79.21)
Table II.- Gender wise distribution of HBV in the 
subjects of Punjab.
Gender Total Positive Negative
Male 318 255 (80.18%) 63 (19.82%)
Female 341 267 (78.30%) 74 (21.70%)
(%) for percentage; n, total number; P=.9043 > 0.05.
The current study showed 4.4% rate of infection in 
the male and 3.55% in females. Moreover, patients of 31-
40 years of age had 5.11% prevalence compared to 2.12% 
in patients above 50 years of age. Ali et al. (2012) have 
reported highest prevalence (i.e. 38.88%) of HBV in people 
belonging to 31 to 40 years age group, while the lowest 
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rate in the age of less than 10 years old children and 7.14% 
in above 50 years old people. In another study the highest 
prevalence rate was 17.16% observed in 16 to 30 years 
aged people (Awan et al., 2012). It was also revealed by 
the current work that HBV prevalence reported in current 
study was mostly associated with chronic conditions, since 
the PCR results were less than HBsAg as shown in Tables 
I and II.
In another study the 19.58% male were infected with 
HBV and 10.16% in females (Ali et al., 2012). Males 
were shown to have 6.03% prevalence and females 5.05% 
(Khan et al., 2006).
The reasons behind this rising rate of infection is 
poor economic background, insufficient health facilities, 
unscreened blood transfusion, high ratio of intravenous 
drug users and minimum awareness about communicable 
diseases in public (Alam et al., 2007). In another study 
the risk factors for possible transmission were observed 
in HBV positive individuals which were reported as 
unhygienic barber practices, general and dental surgery, 
unsafe injection, sharing personal items and blood 
transfusion (Awan et al., 2012).
In the current study it is concluded that real time PCR 
should be performed coupled with ELISA for accurate 
diagnosis of HCV in high prevalence areas (Mahmood et 
al., 2016; Kohmoto et al., 2003; Garson et al., 2005).
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